Our webinar series on Innovative Contracting for Medicines have so far brought you insightful discussions with international industry professionals on why outcome-based agreements for pharmaceuticals are a hot topic right now.
During this webinar, Maarten Halma (Roche) shared his experience with Indication Based Pricing and our senior product experts Marjolein Nanninga and Erik Wiklund (LOGEX) showed how to establish Indication Based Pricing in prostate cancer and create a Pay-for-Performance contract in breast cancer.
This webinar is the third in our series on Innovative Contracting.
To rewatch our first webinar on the subject of why innovative contract matters, click here.
To rewatch our second webinar on the key success factors for innovative contracting, click here.